Endovascular Management of Native Postcoarctation Thoracic Aortic Aneurysms

Postcoarctation thoracic aortic aneurysm formation is one of the most serious complications for coarctation of aorta. Open surgery to repair these aneurysms is associated with high morbidity and mortality. Endovascular therapy is an attractive alternative to open surgery. We have studied the efficacy and safety of endovascular therapy for postcoarctation thoracic aortic aneurysms, and will share our findings and experience through this document.

The data was retrospectively collected on consecutive patients who were presented with postcoarctation thoracic aortic aneurysms at our medical center.

Between January 2006 and May 2016, 5 patients underwent elective endoluminal therapy for postcoarctation thoracic aortic aneurysms. They were treated with stent graft deployment to exclude aneurysms. All procedures were technically successful and there were no perioperative morbidity nor mortality. The median follow-up was 51.6 months (range 3-116 months). All aneurysms remained excluded and stent grafts were patent.

Endovascular repair is a promising alternative to open surgery for native postcoarctation thoracic aortic aneurysms.